Last updated: December 10, 2024
Sponsor: Mayo Clinic
Overall Status: Active - Recruiting
Phase
N/A
Condition
Bronchiectasis
Treatment
POWERBreathe Plus®
Cardiopulmonary rehabilitation post lung transplant
Clinical Study ID
NCT04783155
20-012778
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All patients who undergo single- or double-lung transplant at Mayo Clinic Florida.
Exclusion
Exclusion Criteria:
Patients who do not survive the intra-operative period during the transplantsurgery.
Patients undergoing retransplantation.
Patients undergoing multiorgan transplantation.
Patients who are not willing to or who are unable to give written informed consent.
Study Design
Total Participants: 30
Treatment Group(s): 2
Primary Treatment: POWERBreathe Plus®
Phase:
Study Start date:
May 10, 2021
Estimated Completion Date:
December 31, 2025
Connect with a study center
Mayo Clinic in Florida
Jacksonville, Florida 32224
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.